FOR VETERINARIANS

Webinars

Atopy - the multimodal approach to achieving successful case management
Presented by Dr Dani Hoolahan:
BSc BVMS DACVD
Board Certified Veterinary Dermatologist

How to deal with dermatology cases
Presented by Dr John Hutt:
BVSc(Hons) BA(Hons) MA(CW) CertVD MANZCVS DipACVD
Registered Specialist - Veterinary Dermatology


 

Bite-sized Learning

Dani Hoolahan Webinar - Case study: Spike - food allergy (3 min)

Dani Hoolahan Webinar - Overview of reactive & proactive therapy (2 min)

Dani Hoolahan Webinar - Topical antipruritic therapy (4 min)

Dani Hoolahan Webinar - Wet wrap therapy for severe itch (2 min)

Dani Hoolahan Webinar - Oclacitinib breakthrough pruritus (1 min)

Dani Hoolahan Webinar - Case study: Cody - reactive and proactive management (2 min)

Dani Hoolahan Webinar - Case study: Bruno - when multiple antipruritic therapies are needed (2 min)

John Hutt Webinar - Initial treatment of pruritic patients (2 min)

John Hutt Webinar - Use of steroids at initial appointment (3 min)

Case Studies

Dr Dani Hoolahan webinar - Case study: Bruno - when multiple antipruritic therapies are needed

Dr Dani Hoolahan webinar - Case study: Cody - reactive and proactive management

Dr Dani Hoolahan webinar - Case study: Spike - food allergy

Dr John Hutt - Case study: Effective topical treatment of discoid lupus erythematosus in a Border Collie

Dr John Hutt - Case study: Feline atopic disease: complete resolution when combining ASIT and HCA

Dr Meng Siak - Case study: Feline pemphigus foliaceus: aiding earlier remission with Cortavance (HCA)

Dr Mandy Burrows - Case study: Pemphigus foliaceus in a diabetic patient - when oral glucocorticoids are contraindicated

Virbac Literature

Cortavance detailer 2023

A simplified approach to dermatology cases by Dr John Hutt

Multimodal management of atopic dermatitis in dogs by Dr Dani Hoolahan

Published Literature

Efficacy of proactive use of topical HCA

Efficacy and safety of topical HCA and oclacitinib

Treatment of canine atopic dermatitis: time to revise our strategy?